Watson to Present at the 2010 Citi Investment Research Global Healthcare ... ( MORRISTOWN N.J. About Watson Pharm...)

Watson to Present at the 2010 Citi Investment Research Global Healthcare Conference

Date:5/14/2010

MORRISTOWN, N.J., May 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Fred Wilkinson, Watson's Executive Vice President, Global Brands, will provide an overview of the Company's business at the 2010 Citi Investment Research Global Healthcare Conference on Wednesday, May 26, 2010 at 4:30pm Eastern Daylight Time. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL: http://www.veracast.com/webcasts/citigroup/hc2010/94116472.cfm

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on urology and women's health. Watson has operations in many of the world's established and growing international markets.
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Watson Reaches Settlement with Teva Over Seasonale(R)
2. Watson Confirms EVISTA(R) Patent Challenge
3. Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 7th
4. Watson To Present at Bank Of America/Merrill Lynch 2010 Healthcare Conference
5. Watson Confirms Trilipix(R) Patent Challenge
6. Watson Confirms Rapamune(R) Patent Challenge
7. Watson Confirms Cenestin(R) Patent Challenge
8. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
9. Watson to Present at Barclays 2010 Global Healthcare Conference
10. Watson Receives FDA Approval for Generic Cardizem(R) LA
11. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer

Post Your Comments:

(Date:6/18/2013)... N.J. and NEW YORK , ... and Company) (NYSE: BDX ) are accelerating the ... and glucose sensing technologies through a new collaboration announced today. ... collaborations focused on type 1 diabetes (T1D). Many ... insulin pump – requiring a catheter to be placed in ...

(Date:6/18/2013)... Today, Wall Street Reports announced new research reports ... Management Associates Inc. (NYSE: HMA ), IDEXX Laboratories, ... ISIS ), and Trius Therapeutics Inc. (NASDAQ: TSRX). ... including full price targets, industry analysis and analyst ratings - ... Report On June 7, 2013, Gilead Sciences Inc. ...

(Date:6/18/2013)... June 18, 2013 Remedy Informatics, a ... and life sciences research, today announced it has ... IT Schedule 70 supply contract (GS-35F-367AA, effective May ... innovative IT solutions to government agencies at federal, ... contract, Remedy has placed its products and services ...

Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2 JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6 Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2 Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3 Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4

[0] JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes [0] Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics [0] Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies

... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the Morgan Stanley Global ... 14, 2011 at 9:10 a.m. Eastern Time. Dr. Sands ...

... Sept. 5, 2011 Reportlinker.com ... research report is available in ... Facial Aesthetics (Botox, Dermal Fillers, ... Competitive Landscape and Market Forecasts ...

Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...

(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is ... 40 hours a week of applied behavior analysis (ABA) ... for Autism and Related Disorders (CARD). Riley has been ... experienced remarkable progress, including learning to speak, starting conversations, ... journey through autism is now featured in CARD’s “Mission ...

(Date:6/18/2013)... Recent research has shown that cancer cells have a ... normal cells. Now, scientists at The University of Texas ... provide a new strategy to combat lung cancer. , ... journal PLOS ONE , UT Dallas researchers compared ... normal lung cells taken from the same patient. ...

(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...

(Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...

Breaking Medicine News(10 mins):Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2 Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UT Dallas study suggests new approach to fight lung cancer 2 Health News:UT Dallas study suggests new approach to fight lung cancer 3 Health News:SimuCase avatars advance speech-language pathology training 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3

[0] Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation [0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UT Dallas study suggests new approach to fight lung cancer [0] SimuCase avatars advance speech-language pathology training [0] Allsup Observes National HIV Testing Day June 27

... boosted hearing in such children , THURSDAY, Feb. ... hearing improvement for children and teens with single-sided deafness, ... 3 percent of children have deafness on one side, ... difficulties and behavioral problems. Traditional external hearing aids are ...

... ... NFL Draft pick would have to find a personal trainer, physical therapist, ... them compete with the best athletes in the world. But Athletes, ... offered an NFL Combine preparation program, and this year Trigger Point Performance ...

... , Scientists at the Johns Hopkins Kimmel Cancer Center ... cancer patients to develop individualized blood tests they believe ... blood tests, believed to be the first of their ... therapy and determine cancer recurrence., "We believe this ...

... It is not unusual to hear people blame their metabolism ... process that shapes how our bodies turn food into energy -- ... fit into your favorite jeans. In fact, differences in ... cells, though the mechanism behind it is unclear. Now new research ...

... patients perform significantly better on tests of cognitive function than ... MRI scans of the patients showed that the fitter MS ... show deterioration as a result of MS, as well as ... that aerobic fitness has a protective effect on parts of ...

... ... Opinion Survey and Special Supplement on Health Care Reform , ... Indianapolis, IN (Vocus) February 18, 2010 -- ... benefits advisory organizations, today announced the opening of the 2010 UBA Employer Opinion ...

Cached Medicine News:Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 2 Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 3 Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 2 Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 3 Health News:Chemical tags likely to affect metabolism, cancer development 2 Health News:Exercise helps protect brain of multiple sclerosis patients 2 Health News:Exercise helps protect brain of multiple sclerosis patients 3 Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 2 Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 3

Device Helps Kids With Single-Sided Deafness Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing Chemical tags likely to affect metabolism, cancer development Exercise helps protect brain of multiple sclerosis patients Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform

Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....

For the quantitative determination of iron, total iron-binding capacity in human serum....

HDL Cholesterol, liquid....

Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...

Medicine Products:

Iron / TIBC (Ferrozine)Iron/TIBC Reagent Set HDL Cholesterol (Precipitation)HDL-Cholesterol Direct Reagent